Download User Guide

238 results returned.
Page   of  15

D.C. Code § 48-831.12. Method of prescribing or ordering drugs: Affordability of Prescription Drugs- AccessRx Program – District of Columbia
Status: Enacted     Year Enacted: 2004
The method of prescribing or ordering drugs may include, but is not limited to, the use of standard or larger prescription refill sizes in order to minimize operational costs and maximize economy. Unless the prescribing …
Download
D.C. Code § 48-831.15. Annual summary report: Affordability of Prescription Drugs- AccessRx Program – District of Columbia
Status: Enacted     Year Enacted: 2004
The Department shall submit a written report on the enrollment and financial status of AccessRx to the Council by the 2nd week of January each year.
Download
D.C. Code § 48-831.16. Agreements with governments of other jurisdictions and other entities: Affordability of Prescription Drugs- AccessRx Program – District of Columbia
Status: Enacted     Year Enacted: 2004
The District may negotiate and enter into purchasing alliances and regional strategies with the governments of other jurisdictions, and with other public and private entities, for the purpose of reducing prescription drug prices for residents …
Download
H 1133 (see companion bill S 706) – Massachusetts
Introduced: 2019    Status: Inactive / Dead    
Relative to the pricing of prescription drugs. Health Care Financing. To ensure prescription drug cost transparency and affordability

H 1150 – Massachusetts
Introduced: 2023    Status: In Process    
An Act to ensure access to generic medication

H 1155 – Massachusetts
Introduced: 2021    Status: Inactive / Dead    
An Act to ensure access to generic medications. Before a pharmacy benefits manager or covered entity may place a drug on a maximum allowable cost list the drug must be listed as “A” or “AB” …

H 1202 – Massachusetts
Introduced: 2021    Status: Inactive / Dead    
An Act to ensure access to generic medications. Before a pharmacy benefits manager or covered entity may place a drug on a maximum allowable cost list the drug must be listed as “A” or “AB” …

H 1278 (replaced by S 771) – Massachusetts
Introduced: 2021    Status: Inactive / Dead    
Provides that the Health Policy Commission and health insurers create listings of certain high cost prescription drugs and that the Attorney General require drug manufacturers to provide information to justify increases in costs. Health Care …

H 1279 (see companion bill S 771) – Massachusetts
Introduced: 2021    Status: Inactive / Dead    
For legislation relative to pharmaceutical access, costs and transparency. The assessed amount for pharmaceutical and biopharmaceutical manufacturing companies and pharmacy benefit managers shall be not less than 25 per cent of the amount appropriated by …

H 1307 (replaced by S 771) – Massachusetts
Introduced: 2021    Status: Inactive / Dead    
Relative to the manufacture of generic prescription drugs by the Commonwealth. The study shall examine the factors that most greatly contribute to increasing drug costs in the commonwealth, the ways in which the cost of …

H 4465 – Massachusetts
Introduced: 2021    Status: Inactive / Dead    
For legislation to reduce healthcare costs by promoting non-biased prescriber education. Public Health.

H 4605 (replaced by H4617) – Massachusetts
Introduced: 2018    Status: Inactive / Dead    
AN ACT ESTABLISHING THE HONORABLE PETER V. KOCOT ACT TO ENHANCE ACCESS TO HIGH QUALITY, AFFORDABLE AND TRANSPARENT HEALTHCARE IN THE COMMONWEALTH.

H 4617 (replacd by H 4639) – Massachusetts
Introduced: 2018    Status: Inactive / Dead    
AN ACT ESTABLISHING THE HONORABLE PETER V. KOCOT ACT TO ENHANCE ACCESS TO HIGH QUALITY, AFFORDABLE AND TRANSPARENT HEALTHCARE IN THE COMMONWEALTH.

H 4639 – Massachusetts
Introduced: 2018    Status: Inactive / Dead    
AN ACT ESTABLISHING THE HONORABLE PETER V. KOCOT ACT TO ENHANCE ACCESS TO HIGH QUALITY, AFFORDABLE AND TRANSPARENT HEALTHCARE IN THE COMMONWEALTH.

H 713 – Vermont
Introduced: 2018    Status: Inactive / Dead    
Prohibits prescription drug manufacturers and wholesale distributors from engaging in price gouging in the sale of essential off-patent or generic drugs. The Department of Vermont Health Access may notify the Attorney General of any increase …

H 931 – Massachusetts
Introduced: 2019    Status: Inactive / Dead    
Relative to the quality of healthcare and healthcare benefits and insurance. Financial Services. Promoting high value and high quality care

238 results returned.
Page   of  15

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.